BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,080 filers reported holding BAXTER INTL INC in Q1 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $766,235 | +6.8% | 20,303 | +28.9% | 0.15% | +8.0% |
| Q2 2023 | $717,752 | -5.1% | 15,754 | -15.5% | 0.14% | -9.2% |
| Q1 2023 | $756,606 | -12.7% | 18,654 | +9.7% | 0.15% | -17.4% |
| Q4 2022 | $866,440 | +2.2% | 16,999 | +8.0% | 0.18% | -3.7% |
| Q3 2022 | $848,000 | -20.6% | 15,740 | -5.4% | 0.19% | -18.4% |
| Q2 2022 | $1,068,000 | -0.4% | 16,634 | +20.4% | 0.23% | +6.8% |
| Q1 2022 | $1,072,000 | -6.1% | 13,819 | +3.8% | 0.22% | -9.1% |
| Q4 2021 | $1,142,000 | +28.6% | 13,307 | +20.6% | 0.24% | +18.1% |
| Q3 2021 | $888,000 | +4.8% | 11,034 | +4.9% | 0.20% | -2.4% |
| Q2 2021 | $847,000 | -4.5% | 10,523 | +0.0% | 0.21% | -11.1% |
| Q1 2021 | $887,000 | +5.1% | 10,520 | +0.0% | 0.24% | -1.3% |
| Q4 2020 | $844,000 | -0.4% | 10,517 | -0.2% | 0.24% | -18.2% |
| Q3 2020 | $847,000 | +18.0% | 10,537 | +26.4% | 0.29% | +3.2% |
| Q2 2020 | $718,000 | +0.1% | 8,337 | -5.5% | 0.28% | -20.3% |
| Q1 2020 | $717,000 | -2.7% | 8,826 | +0.2% | 0.35% | +42.2% |
| Q4 2019 | $737,000 | -4.4% | 8,811 | 0.0% | 0.25% | -26.3% |
| Q3 2019 | $771,000 | +6.8% | 8,811 | 0.0% | 0.34% | +8.3% |
| Q2 2019 | $722,000 | -1.0% | 8,811 | -1.8% | 0.31% | -3.4% |
| Q1 2019 | $729,000 | +24.8% | 8,971 | +1.2% | 0.32% | +10.6% |
| Q4 2018 | $584,000 | -80.3% | 8,869 | -76.9% | 0.29% | -76.7% |
| Q3 2018 | $2,958,000 | +2.6% | 38,374 | -1.7% | 1.25% | -7.7% |
| Q2 2018 | $2,884,000 | +11.7% | 39,056 | -1.6% | 1.36% | +7.8% |
| Q1 2018 | $2,581,000 | +5.0% | 39,684 | +4.4% | 1.26% | +5.6% |
| Q4 2017 | $2,458,000 | +4.0% | 38,023 | +1.0% | 1.19% | -0.3% |
| Q3 2017 | $2,363,000 | +12.6% | 37,659 | +8.7% | 1.20% | +5.2% |
| Q2 2017 | $2,098,000 | +17.0% | 34,649 | +0.2% | 1.14% | +12.3% |
| Q1 2017 | $1,793,000 | +14.6% | 34,580 | -2.0% | 1.01% | +2.2% |
| Q4 2016 | $1,565,000 | -6.7% | 35,300 | +0.2% | 0.99% | -8.8% |
| Q3 2016 | $1,678,000 | +5.3% | 35,244 | +0.0% | 1.09% | +4.5% |
| Q2 2016 | $1,593,000 | +3.0% | 35,232 | -6.4% | 1.04% | -4.0% |
| Q1 2016 | $1,547,000 | +7.7% | 37,650 | +0.0% | 1.08% | +2.8% |
| Q4 2015 | $1,436,000 | +7.6% | 37,637 | -7.4% | 1.05% | 0.0% |
| Q3 2015 | $1,334,000 | -52.9% | 40,623 | +0.3% | 1.05% | -49.7% |
| Q2 2015 | $2,833,000 | +2.2% | 40,518 | +0.1% | 2.10% | -6.1% |
| Q1 2015 | $2,773,000 | -6.4% | 40,487 | +0.1% | 2.23% | -18.7% |
| Q4 2014 | $2,963,000 | – | 40,427 | – | 2.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |